Ocugen | Evaluate

September 07, 2021

As Forte fails, who might yet improve the image of reverse mergers?

Among developers that arrived on the market via reverse mergers, big success stories are hard to find.

Alzheimer’s and Covid-19 developers make hay on the stock markets

Big risers include Eli Lilly, Biogen, Moderna and Biontech.

May 19, 2021

Glaxo’s Covid-19 effort progresses, this time thanks to Medicago

April 22, 2021

Valneva joins the phase 3 Covid-19 vaccine club

Meanwhile, Ocugen hopes that Covaxin's India data will be enough for US approval.

February 19, 2021

Immunome soars 76% on Covid-19 hopes – but that's nothing